BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26318860)

  • 1. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
    Tan J; Qiu K; Li M; Liang Y
    FEBS Lett; 2015 Oct; 589(20 Pt B):3175-81. PubMed ID: 26318860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
    Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
    Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
    Xue M; Pang H; Li X; Li H; Pan J; Chen W
    Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
    Jiang H; Hu X; Zhang H; Li W
    Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer.
    Wang Y; Zhou Y; Yang Z; Chen B; Huang W; Liu Y; Zhang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317690998. PubMed ID: 28675122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
    Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
    Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
    Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
    Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA TUG1 regulates ovarian cancer proliferation and metastasis via affecting epithelial-mesenchymal transition.
    Kuang D; Zhang X; Hua S; Dong W; Li Z
    Exp Mol Pathol; 2016 Oct; 101(2):267-273. PubMed ID: 27693324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
    Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
    Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT.
    Zhuang J; Lu Q; Shen B; Huang X; Shen L; Zheng X; Huang R; Yan J; Guo H
    Sci Rep; 2015 Jul; 5():11924. PubMed ID: 26152796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
    Hu Z; Lin Y; Chen H; Mao Y; Wu J; Zhu Y; Xu X; Xu X; Li S; Zheng X; Xie L
    Biochem Biophys Res Commun; 2013 May; 435(1):82-7. PubMed ID: 23618864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
    Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B
    Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
    Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
    Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma.
    Qin Y; Zhang Y; Tang Q; Jin L; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.